抗体-药物联合体:从瘤学里程碑到新兴的非瘤学应用
1Department of Biosciences and Bioengineering, Indian Institute of Technology, Roorkee, Uttarakhand, India.
International immunopharmacology
|January 8, 2026
概括
抗体-药物合物 (ADC) 正在发展为向疗法,将单克隆抗体与强大的癌症治疗有效载荷相结合. 它们的应用正在扩展到自身免疫性,炎症性和传染性疾病,展示了多功能治疗潜力.
科学领域:
- 生物医学科学 生物医学科学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 抗体与药物联合体 (ADCs) 在向治疗方面取得了重大进展.
- ADCs将单克隆抗体 (mAbs) 与强大的细胞毒性有效载荷相结合,以提高选择性.
- 最近ADC设计的演变改善了稳定性和治疗范围,导致FDA批准.
研究的目的:
- 审查瘤学中ADCs的基本组成部分,机制和临床演变.
- 突出非瘤学指标的ADCs的发展,包括自身免疫性,炎症性和传染性疾病.
- 探索在不同治疗领域基于ADC的有针对性治疗的新兴转化机会.
主要方法:
- 关于ADC开发和临床应用的文献综述.
- 对ADC设计优化的分析 (抗体,链接器,有效载荷).
- 在瘤学之外探索ADC应用.
主要成果:
- ADCs在瘤学方面取得了显著的成功,并获得了多项FDA批准.
- ADC技术已经发展,提高了选择性,稳定性和治疗结果.
- 新兴的ADC应用在治疗自身免疫性,炎症性和传染性疾病方面表现有前途.
结论:
- 抗癌药是一种强大的向治疗类药物,在瘤学中具有经过验证的记录.
- ADC设计的多功能性允许扩展到非瘤治疗领域.
- 对ADC开发和应用的进一步研究对各种疾病具有显著的翻译潜力.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Drug Products: Biologics, Biosimilars and Interchangeables
229
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
229
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


